There are no IPOs expected to price in the week ahead. To date, six IPOs have raised a combined $1.1 billion this month, the lowest number since 2011, when four IPOs raised $937 million. Although ...read more
Three companies priced their IPOs this week raising $289 million. Technology-driven real estate brokerage Redfin and dermatology biotech Sienna Biopharmaceuticals both soared over 25% in their debuts. ...read more
Sienna Biopharmaceuticals, a clinical-stage biotech developing topical therapies for dermatological conditions, raised $65 million by offering 4.3 million shares at $15, the midpoint of the range of $14 to $16. Insiders had indicated an interest in buying up to...read more
Four deals, each representing a different sector, are on the IPO calendar for the week ahead looking to raise a combined $454 million. Redfin, which headlines the group, is the biggest name to IPO since Blue Apron in June, and its reception could be a signal for...read more
US IPO Week Ahead: No IPOs during eclipse week, but keep an eye out for filings
There are no IPOs expected to price in the week ahead. To date, six IPOs have raised a combined $1.1 billion this month, the lowest number since 2011, when four IPOs raised $937 million. Although ...read more
US IPO Weekly Recap: Brokerage Redfin and biotech Sienna soar, RBB bancorp flat
Three companies priced their IPOs this week raising $289 million. Technology-driven real estate brokerage Redfin and dermatology biotech Sienna Biopharmaceuticals both soared over 25% in their debuts. ...read more
Sienna Biopharmaceuticals prices IPO at $15 midpoint
Sienna Biopharmaceuticals, a clinical-stage biotech developing topical therapies for dermatological conditions, raised $65 million by offering 4.3 million shares at $15, the midpoint of the range of $14 to $16. Insiders had indicated an interest in buying up to...read more
US IPO Week Ahead: A real estate brokerage, a bank and a biotech
Four deals, each representing a different sector, are on the IPO calendar for the week ahead looking to raise a combined $454 million. Redfin, which headlines the group, is the biggest name to IPO since Blue Apron in June, and its reception could be a signal for...read more